Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Trinity Bio ADR

(NASDAQ: TRIB)
Add to Portfolio
+0.04 (+4.17%)
as of Feb 21, 2020

Last 1.00
Change +0.04 (+4.17%)
Open 1.00
Prev. Close 0.96
Today's Range
0.99
1.02
52wk Range
0.63
3.36
Volume 42,536
Avg Volume 268,496
Sector SIC-2835 In Vitro & In Vivo Diagnostic Substances

Perfomance Comparison

Name Today 3-Month 1-Year
TRIB +4.17% +2.03% -66.67%
DJIA -0.78% +3.88% +12.15%
S&P 500 -1.05% +6.43% +20.28%

Key Statistics

Annual EPS -1.07
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 23,530
Weighted Alpha -69.90
Standard Deviation +0.75
Profit Margin 18.65%
Beta 1.61

Growth Rates

YTD -3.23%
1-Year -69.62%
3-Year -84.81%
5-Year -94.59%
10-Year -81.07%

Opinion

Sell Hold Buy

Recent Headlines

Point of Care Testing Market Insights and In-Depth

Market Insight Reports via COMTEX - Mon Jan 06, 06:27AM EST
CEMI: 3.94 (+0.06), OSUR: 6.09 (-0.04), TRIB: 1.00 (+0.04)

Trinity Biotech Announces Results for Q3, 2019

GlobeNewswire via COMTEX - Wed Oct 16, 08:04AM EDT
Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2019.(full story)
TRIB: 1.00 (+0.04)

Trinity Biotech plc to Announce Third Quarter Fiscal

GlobeNewswire via COMTEX - Tue Oct 15, 11:40AM EDT
October 15, 2019 - Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the third quarter fiscal y(full story)
TRIB: 1.00 (+0.04)

Trinity Biotech plc to Announce Second Quarter Fiscal

GlobeNewswire via COMTEX - Thu Aug 15, 02:07PM EDT
Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter fiscal year 2019 on Tuesda(full story)
TRIB: 1.00 (+0.04)